PGPIPN is a therapeutic hexapeptide (Pro-Gly-Pro-Ile-Pro-Asn) researched for its immunomodulatory and anti-inflammatory properties, particularly in chronic inflammatory conditions and tissue repair. It is an emerging research peptide with limited but promising preclinical data.
Category: Immune & Anti-inflammatory. Evidence rating: D (animal/preclinical only).
Clinical status: Preclinical research. Limited published studies.
Hexapeptide with immunomodulatory and anti-inflammatory properties that may help regulate inflammatory responses in damaged tissue. Exact molecular targets are still being characterized.
Safety considerations: No human safety data; Preclinical toxicity profile not fully characterized; Emerging research compound.
Reviewed by the PeptideAtlas Editorial Team.
| Amino-acid sequence | Pro-Gly-Pro-Ile-Pro-Asn |
|---|---|
| Molecular weight | ~579 Da |
| Production method | synthetic |
| US regulatory status | Research compound only. |
No, it is an emerging research peptide with very limited published literature. It should be considered highly experimental.
PGPIPN is a therapeutic hexapeptide (Pro-Gly-Pro-Ile-Pro-Asn) researched for its immunomodulatory and anti-inflammatory properties, particularly in chronic inflammatory conditions and tissue repair.
PGPIPN has been studied for: Anti-inflammatory potential, Tissue repair support, Immunomodulation. Emerging research peptide; limited clinical data.
Hexapeptide with immunomodulatory and anti-inflammatory properties that may help regulate inflammatory responses in damaged tissue.